Hoyne G F, Callow M G, Kuhlman J, Thomas W R
Division of Molecular Biology, Western Australian Research Institute for Child Health, Princess Margaret Hospital, Perth.
Immunology. 1993 Apr;78(4):534-40.
Feeding antigens induces an immunological unresponsiveness termed oral tolerance but under some conditions, for example following the administration of cyclophosphamide (CY), immunity can be induced. These observations have usually been made by studying antibody production and delayed hypersensitivity with little attention given to other measurements of cellular activation. We have therefore examined the lymphokines produced by T cells obtained after the induction of oral tolerance or intragastric priming. Cells isolated from the spleen and Peyer's patches (PP) of tolerized mice could secrete high levels of interferon-gamma (IFN-gamma) and moderate levels of granulocyte-macrophage colony-stimulating factor (GM-CSF) in response to antigen while interleukin-2 (IL-2), IL-3 and IL-4 could not be detected. Mesenteric lymph node (MLN) cells of tolerized mice did not respond to antigen unless spleen adherent cells were added to the cultures where IFN-gamma and GM-CSF were produced. Intragastric priming was achieved by feeding antigen to CY-treated mice. T cells from the spleen, MLN and PP of these mice could produce GM-CSF, IFN-gamma, some IL-3 but little or no IL-2 and IL-4. The ability of MLN cells to proliferate with antigen in vitro was low and corresponded to low IL-2 production. Thus T cells from fed mice secrete a defined pattern of lymphokines which differs in tolerizing and priming regimes.
喂食抗原会诱导一种称为口服耐受的免疫无反应状态,但在某些条件下,例如给予环磷酰胺(CY)后,可诱导免疫反应。这些观察结果通常是通过研究抗体产生和迟发型超敏反应得出的,很少关注细胞活化的其他测量指标。因此,我们研究了在诱导口服耐受或胃内致敏后获得的T细胞产生的淋巴因子。从耐受小鼠的脾脏和派伊尔结(PP)分离的细胞在接触抗原时可分泌高水平的干扰素-γ(IFN-γ)和中等水平的粒细胞-巨噬细胞集落刺激因子(GM-CSF),而白细胞介素-2(IL-2)、IL-3和IL-4无法检测到。耐受小鼠的肠系膜淋巴结(MLN)细胞对抗原无反应,除非在产生IFN-γ和GM-CSF的培养物中加入脾脏黏附细胞。通过给经CY处理的小鼠喂食抗原来实现胃内致敏。这些小鼠的脾脏、MLN和PP中的T细胞可产生GM-CSF、IFN-γ、一些IL-3,但很少或不产生IL-2和IL-4。MLN细胞在体外与抗原一起增殖的能力较低,这与低水平的IL-2产生相对应。因此,来自喂食小鼠的T细胞分泌一种特定模式的淋巴因子,这种模式在耐受和致敏方案中有所不同。